Improving Bladder Function in SCI by Neuromodulation
- Conditions
- Spinal Cord Injury
- Interventions
- Device: Electromagnetic Neuromodulation
- Registration Number
- NCT02331979
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.
- Detailed Description
This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury. Neuromodulation will be in the form of transcutaneous electrical stimulation and/or magnetic stimulation.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 24
- Male 18-45 years;
- At least 1 year post-injury;
- Non-progressive SCI at C2-T8 (non-conus injury);
- Motor Complete ASIA (A or B);
- Neurogenic bladder requiring clean intermittent straight catheterization;
- Able to attend twice weekly testing sessions for 6 months.
- Have intact lower extremity anatomy and able to use lower extremity for assistive standing and stepping.
-
History of autonomic dysreflexia;
-
Ventilator dependency;
-
Musculoskeletal dysfunction, unhealed fracture, pressure ulcer, active infection;
-
Clinically significant depression or ongoing drug abuse;
-
Received botox injection, or bladder surgery (suprapubic access, Brindley procedure, etc.); 6. Prostatic hypertrophy or bladder outlet disorder;
-
Cardiopulmonary disease that precludes lower extremity training or rehabilitation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Stimulation of Non-Naive Electromagnetic Neuromodulation Evaluate neuromodulation in 6 subjects with prior motor training. Stimulation Electromagnetic Neuromodulation Apply parameters discovered in Arm 1 and Arm 2 to evaluate neuromodulation in 12 naive subjects. Stimulation of Naive Electromagnetic Neuromodulation Evaluate neuromodulation in 6 naive subjects.
- Primary Outcome Measures
Name Time Method Urine flow and volume Months 1-48
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of California, Los Angeles
🇺🇸Los Angeles, California, United States